Trial Profile
A Phase 2 Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 04 Jun 2015
Price :
$35
*
At a glance
- Drugs IAB 2M (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Sponsors ImaginAb Inc
- 01 Jun 2015 Status changed from recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 27 Apr 2015 New trial record